QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy

Starting soon

Conditions studied: Cancer, Type 2 Diabetes

In brief

The goal of this observational study is to see how type 2 diabetes affects quality of life in cancer patients receiving immunotherapy. We want to know if patients with diabetes have a greater decline in quality of life over six months compared to those without. The main question we aim to answer is: \- How does quality of life change over six months in patients with versus without diabetes? Participants will complete quality-of-life surveys at the start, then at 3 and 6 months. This will help us see if diabetes adds extra challenges during cancer treatment

Key facts

Study ID
NCT07466212
Run by
Odense University Hospital
People needed
920
Starts
2026-03-10
Expected to finish
2027-10-01
Last updated by the study team
2026-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.